Cargando…

Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada

BACKGROUND: Amid the opioid crisis, the health care system is restructuring to prevent and treat COVID-19. Individuals in opioid agonist treatment (OAT) are uniquely challenged because of disruption to treatment, medication diversion, and isolation during the pandemic. METHODS: Between January and S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morin, Kristen A., Acharya, Shreedhar, Eibl, Joseph K., Marsh, David C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier B.V. 2021
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834895/ https://www.ncbi.nlm.nih.gov/pubmed/33385974 http://dx.doi.org/10.1016/j.drugpo.2020.103088

Ejemplares similares

Evidence of Increased Age and Sex Standardized Death Rates Among Individuals Who Accessed Opioid Agonist Treatment Before the Era of Synthetic Opioids in Ontario, Canada
por: Morin, Kristen A, et al.
Publicado: (2021)

Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2021)

The opioid crisis: past, present and future policy climate in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2017)

The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada
por: Franklyn, Alexandra M., et al.
Publicado: (2017)

Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada
por: Morin, Kristen A., et al.
Publicado: (2019)

Evaluating the effectiveness of concurrent opioid agonist treatment and physician-based mental health services for patients with mental disorders in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2020)

Correction to: Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada
por: Morin, Kristen A., et al.
Publicado: (2019)

A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2020)

Measuring treatment attrition at various stages of engagement in Opioid Agonist Treatment in Ontario Canada using a cascade of care framework
por: Tahsin, Farah, et al.
Publicado: (2022)

A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health data
por: Morin, Kristen A., et al.
Publicado: (2020)

Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort study
por: Morin, Kristen A, et al.
Publicado: (2022)

The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
por: Franklyn, Alexandra M., et al.
Publicado: (2017)

Too much or never enough: a response to Treatment of opioid disorders in Canada: looking at the ‘other epidemic’
por: Eibl, Joseph K., et al.
Publicado: (2016)

Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
por: Franklyn, Alexandra M., et al.
Publicado: (2017)

Characterizing the Use of Telepsychiatry for Patients with Opioid Use Disorder and Cooccurring Mental Health Disorders in Ontario, Canada
por: LaBelle, Brittanie, et al.
Publicado: (2018)

Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021
por: Rosic, Tea, et al.
Publicado: (2023)

Reductions in non-medical prescription opioid use among adults in Ontario, Canada: are recent policy interventions working?
por: Fischer, Benedikt, et al.
Publicado: (2013)

Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey
por: Kouyoumdjian, Fiona G., et al.
Publicado: (2018)

Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis
por: Garg, Ria, et al.
Publicado: (2022)

Measuring the Burden of Opioid-related Mortality in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
por: Russell, Cayley, et al.
Publicado: (2022)

Measuring the Burden of Opioid-Related Mortality in Ontario, Canada, During the COVID-19 Pandemic
por: Gomes, Tara, et al.
Publicado: (2021)

Changes in Children and Youth’s Mental Health Presentations during COVID-19: A Study of Primary Care Practices in Northern Ontario, Canada
por: Daneshmand, Roya, et al.
Publicado: (2023)

Relative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada
por: Hsu, Sylvia H., et al.
Publicado: (2021)

Prevalence of Prenatal Opioid Exposure in Ontario, Canada, 2014-2019
por: Camden, Andi, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis
por: Kitchen, Sophie A., et al.
Publicado: (2022)

Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2022)

Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada
por: Eibl, Joseph K., et al.
Publicado: (2015)

Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study
por: Russell, Cayley, et al.
Publicado: (2022)

Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015–2018: a repeated cross-sectional analysis
por: Bodkin, Claire, et al.
Publicado: (2021)

Association of prescribed oral stimulants on cocaine use among patients enrolled in opioid agonist treatment: A retrospective longitudinal cohort study
por: Tatangelo, Mark, et al.
Publicado: (2022)

Burden of opioid toxicity death in the fentanyl-dominant era for people who experience incarceration in Ontario, Canada, 2015–2020: a whole population retrospective cohort study
por: Butler, Amanda, et al.
Publicado: (2023)

The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting
por: Mackay, Lindsay, et al.
Publicado: (2021)

The Use of Telemedicine in Older-Adults During the COVID-19 Pandemic: a Weekly Cross-Sectional Analysis in Ontario, Canada
por: Chu, Cherry, et al.
Publicado: (2022)

Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2022)

Activation of the μ‐opioid receptor by alicyclic fentanyls: Changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure
por: Åstrand, Anna, et al.
Publicado: (2020)

Artificial Domicile Use by Bumble Bees (Bombus; Hymenoptera: Apidae) in Ontario, Canada
por: Johnson, Sarah A, et al.
Publicado: (2019)

New opioid use and risk of opioid-related adverse events among adults with intellectual and developmental disabilities in Ontario, Canada
por: Guan, Qi, et al.
Publicado: (2022)

The distribution of alcohol-attributable healthcare encounters across the population of alcohol users in Ontario, Canada
por: Andreacchi, Alessandra T., et al.
Publicado: (2023)

Greater Opioid Use Among Nursing Home Residents in Ontario, Canada During the First 2 Waves of the COVID-19 Pandemic
por: Maxwell, Colleen J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e4156ma6m0bvhcvvt7cs1bosdt